BCG2 and Spitfire raise a toast to good health after winning more Pfizer business

  • Advertising
  • July 26, 2011
  • StopPress Team
BCG2 and Spitfire raise a toast to good health after winning more Pfizer business

bcg2 Health and Spitfire have snaffled a couple more Pfizer brands, after the two combined forces to win the haemophilia treatments pitch for the Xyntha and BeneFIX products in the Australian market against two Aussie agencies. This win adds to the New Zealand haemophilia business that was won in November last year.General manager of bcg2 Health, Stuart Ogden, said the two agencies worked together to provide "a perfect blend of specialist healthcare knowledge and communication skills, combined with specialist digital strategy and production".

“It’s great to gain even more traction in this market on the strengths of our efforts in New Zealand, as we further establish ourselves as healthcare communication specialists across the Tasman."

“We see the healthcare markets really embracing digital technology," says John Madden, creative director from Spitfire, 'a creative agency with digital at the core of the business'. "It allows us to connect healthcare professionals with their patients in ways that add value to the relationship and feels intuitive to users. Working closely with the bcg2 Health team is proving to be incredibly valuable."

Over the past seven months, bcg2 Health has pitched and won two other campaigns from Pfizer’s New Zealand Speciality Care Division. The first is a campaign for Prevenar 13, an infant vaccine for pneumococcal disease and the second is Enbrel, which is used to treat Rheumatoid Arthritis and Psoriasis. These were in addition to being awarded Pfizer’s Avigra in April.

As well as new business, bcg2 Health also has a new human after hiring Helen Purcell, a specialist healthcare group account director (managing director Sarah Norrie departed in March and is now working on the Labour party's campaign).

Purcell is a recent arrival from New York, where she worked in the pharmaceutical communications area for the previous sixteen years at leading agencies like Y&R, Ogilvy and Grey. With prior experience working on Pfizer brands in the USA Helen will be responsible for Pfizer New Zealand business and the haemophilia portfolio in Australia.

This is a community discussion forum. Comment is free but please respect our rules:

  1. Don’t be abusive or use sweary type words
  2. Don’t break the law: libel, slander and defamatory comments are forbidden
  3. Don’t resort to name-calling, mean-spiritedness, or slagging off
  4. Don’t pretend to be someone else.

If we find you doing these things, your comments will be edited without recourse and you may be asked to go away and reconsider your actions.
We respect the right to free speech and anonymous comments. Don’t abuse the privilege.

The case for collaboration: Garage Project talks partnerships from production to promotion

  • advertsing
  • September 20, 2019
  • Courtney Devereux
The case for collaboration: Garage Project talks partnerships from production to promotion

Collaborations provide more than just a new product, it provides an opportunity for two brands to leverage each other's audiences and learn new ways of promoting. We spoke with Pete Gillespie, co-founder of Garage Project as to why he thinks partnerships are key to keeping the energy alive when creating new campaigns.

Read more
Next page
Results for

StopPress provides essential industry news and intelligence, updated daily. And the digital newsletter delivers the latest news to your inbox twice a week — for free!

©2009–2019 ICG Media. All rights reserved.
Use of this site constitutes acceptance of our Privacy policy.


Contact Vernene Medcalf at +64 21 628 200 to advertise in StopPress.

View Media Kit